Nuveen
MGNX icon

Nuveen’s MacroGenics MGNX Stock Holding History

Nuveen’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$609K Buy
+131,753
New +$498K ﹤0.01% 3177
2025
Q2 		– Sell
-198,470
Closed -$252K – 3347
2025
Q1 		$252K Hold
198,470
– – ﹤0.01% 3072
2024
Q4 		$645K Hold
198,470
– – ﹤0.01% 2889
2024
Q3 		$653K Hold
198,470
– – ﹤0.01% 2922
2024
Q2 		$843K Sell
198,470
-351,170
-64% -$3.42M ﹤0.01% 2803
2024
Q1 		$8.09M Sell
549,640
-57,571
-9% -$870K ﹤0.01% 1735
2023
Q4 		$5.84M Sell
607,211
-327,770
-35% -$2.27M ﹤0.01% 1897
2023
Q3 		$4.36M Sell
934,981
-1,476
-0.2% -$7.35K ﹤0.01% 1933
2023
Q2 		$5.01M Buy
936,457
+252,840
+37% +$1.56M ﹤0.01% 1911
2023
Q1 		$4.9M Buy
683,617
+166,058
+32% +$1M ﹤0.01% 1901
2022
Q4 		$3.47M Buy
517,559
+20,120
+4% +$110K ﹤0.01% 2119
2022
Q3 		$1.72M Buy
497,439
+170,615
+52% +$653K ﹤0.01% 2473
2022
Q2 		$965K Buy
326,824
+23,070
+8% +$121K ﹤0.01% 2792
2022
Q1 		$2.66M Sell
303,754
-38,731
-11% -$428K ﹤0.01% 2377
2021
Q4 		$5.5M Sell
342,485
-9,275
-3% -$175K ﹤0.01% 2063
2021
Q3 		$7.37M Sell
351,760
-24,716
-7% -$595K ﹤0.01% 1996
2021
Q2 		$10.1M Sell
376,476
-27,027
-7% -$791K ﹤0.01% 1855
2021
Q1 		$12.9M Sell
403,503
-469,718
-54% -$11.4M ﹤0.01% 1636
2020
Q4 		$20M Sell
873,221
-18,746
-2% -$432K 0.01% 1269
2020
Q3 		$6.78M Buy
891,967
+127,172
+17% +$3.47M ﹤0.01% 1755
2020
Q2 		$5.81M Sell
764,795
-126,760
-14% -$2.2M ﹤0.01% 1816
2020
Q1 		$5.19M Buy
891,555
+184,660
+26% +$1.68M ﹤0.01% 1696
2019
Q4 		$7.69M Buy
706,895
+3,007
+0.4% +$29.8K ﹤0.01% 1746
2019
Q3 		$8.98M Sell
703,888
-95,235
-12% -$1.37M ﹤0.01% 1644
2019
Q2 		$13.6M Buy
+799,123
New +$13.7M 0.01% 1412

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Nuveen's MGNX Position: Q2 2026 in Review

Nuveen opened a new position in MacroGenics (MGNX) in Q2 2026: 131,753 shares worth $609K. The stake represents ﹤0.01% of the portfolio and ranks #3177 among its holdings. This is a return to the name: Nuveen previously reported a position in MGNX as recently as Q1 2025.

Nuveen first reported a position in MGNX in Q2 2019 and has held it in 25 quarters since. The position peaked at $20M in Q4 2020. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Nuveen held 131,753 shares of MacroGenics worth $609K as of Q2 2026.
  • MacroGenics was a new Nuveen position in Q2 2026.
  • MacroGenics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3177 holding.
  • Nuveen first reported a position in MacroGenics in Q2 2019 and has held it in 25 quarters since.
  • Nuveen's MacroGenics position peaked at $20M in Q4 2020.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.